Regulatory Compliant – no royalty fees

The CHO-GS expression system enables rapid identification of clones expressing high levels of recombinant therapeutic protein during development of a stable cell line. Flexible licensing term ensures that access to this high-performance cell line platform is easily accessible to meet the demands for cost effective biomanufacturing. 


The CHO-GS expression system consists of:

  • 1 vial of 10x106 cGMP Horizon CHO cells
  • A Dual promoter expression vector
  • Protocols and technical support
  • Traceability documentation detailing the derivation of the cells and adventitious agents testing results to support regulatory filings



To discuss your bioproduction/biomanufacturing cell line needs and to find out how we can meet them, please contact us.